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Abstract 
Background: Most studies on the effects of SARS‑CoV‑2 infection have been conducted with adults and non‑preg‑
nant women. Thus, its impacts on maternal health are not yet fully established. This study aimed to verify the relation‑
ship between the maternal mortality ratio and the incidence of COVID‑19 in the State of Bahia, Brazil, 2020.
Methods: This time‑series study used publicly available information in Brazil, to obtain data on maternal deaths and 
live births in Bahia, State, from January 1, 2011, to December 31, 2020. The time trend of Maternal Mortality Ratio 
(MMR) was analysed through polynomial regression, of order 6. Expected MMR, monthly (Jan‑Dec) and annual values 
for 2020, were predicted by the additive Holt‑Winters exponential smoothing algorithm, with 95% confidence inter‑
val, based on the time series of the MMR from 2011 to 2019, and the accuracy of the forecasts for 2020 was assessed 
by checking the smoothing coefficients and the mean errors. According to the statistical forecast, the MMR values  
recorded in the year 2020 were compared to those expected.
Results: In 2020, the annual MMR in Bahia, Brazil, was 78.23/100,000 live births, 59.46% higher than the expected 
ratio (49.06 [95% CI 38.70–59.90]). The increase in maternal mortality ratio relative to expected values was observed 
throughout the 2020 months; however, only after May, when the COVID‑19 epidemic rose sharply, it exceeded the 
upper limit of the 95% CI of the monthly prediction. Of the 144 registered maternal deaths in 2020, 19 (13.19%) had 
COVID‑19 mentioned as the cause of death.
Conclusions: Our study revealed the increase in maternal mortality, and its temporal relationship with the incidence 
of COVID‑19, in Bahia, Brazil, in 2020. The COVID‑19 pandemic may be directly and indirectly related to this increase, 
which needs to be investigated. An urgent public health action is needed to prevent and reduce maternal deaths 
during this pandemic, in Brazil.
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Introduction
The emergence and global spread of the novel coronavi-
rus, SARS-CoV-2, from December 2019, caused a respira-
tory disease (COVID-19) pandemic which was already 
affected until February 11, 2021 107,818,965 individuals 
and 2,362,704 deaths in the world [1]. The COVID 19 pan-
demic hit Brazil in February 2020, and 1 year later 9,524,640 
cases and 231,534 deaths were reported, corresponding to 
2,4% case fatality rate, and mortality rate of 110.2 deaths 
per 100,000 inhabitants [2], being on that date, the third 
country with the highest number of cases worldwide [1].
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The clinical and epidemiological profile observed, at 
the beginning of the epidemic in China, showed that 
elderly (60 years old or more) with comorbidities such 
as diabetes, hypertension, heart disease, obesity, pneu-
mopathies and immunosuppressed individuals were at 
higher risk for complications and deaths for COVID19, 
as has been observed in many countries affected by this 
pandemic [3–6]. At earlier stages of the epidemic, preg-
nant women without comorbidities were not considered 
at greater risk for COVID-19 and its related complica-
tions. However, with the greater spread of this disease, 
some authors began to describe the occurrence of severe 
forms, as well as abortion and deaths, even among preg-
nant women without comorbidities [7, 8].
These findings have been reported in many countries 
such as the United States, United Kingdom, France, 
Mexico and Brazil [2, 9–12], and contributed to subsidise 
PAHO, to issue an Alert in August 2020, encouraging 
member countries to redouble efforts to ensure access 
and continuity of prenatal care, with special attention 
to the early detection of signs, symptoms, and severity 
of clinical manifestations of COVID-19 [13]. It is known 
that during pregnancy the women present a relative 
immunodeficiency and it could worsen the clinical evolu-
tion of COVID 19 and lead to negative outcomes in the 
mothers and foetus [14].
Brazil is a middle-income country where the mater-
nal mortality is still high [15] although it has been pre-
senting a slow declining trend [16, 17]. Since the 1990 s, 
improvements in the living and health conditions of 
the population in this country, which includes women 
of reproductive age, have contributed to an important 
reduction in maternal deaths [18], but not enough to 
reach the Brazilian government target of less than 30 
maternal deaths for every 100,000 live births [19]. Then, 
the COVID-19 pandemic may negatively influence the 
evolution of this indicator in Brazil.
Given the uncertainties about the possible impact of 
the COVID-19 on maternal mortality, this study aimed 
to verify the relationship between the maternal mortal-
ity ratio and the incidence of COVID-19 in the State of 
Bahia, Brazil, 2020.
Methods
A retrospective time series study was carried out on 
maternal mortality during the COVID 19 pandemic in 
Bahia, Brazil, 2020. Maternal death was defined as estab-
lished by the World Health Organization’s International 
Classification of Diseases (ICD-10) [20].
The website of the Bahia State Health Secretariat [21] 
was accessed to obtain the data for this study. Epide-
miological bulletins [22] were the sources of data on 
the number of new cases of COVID-19 and population 
estimate, in Bahia. According to the month of occur-
rence, the number of maternal deaths and live births, 
from January 2011 to December 2020, were extracted 
from the public domain health open data, DATASUS 
[23, 24]. The DATASUS aggregates health data from 
different Brazilian official information systems. Data on 
maternal deaths come from the Mortality Information 
System (SIM), which in 2011 reached 96.1% nationwide 
coverage [25]. Data on live births come from the Live 
Birth Information System (SINASC), which in 2010 has 
coverage of 94,8% in Brazil, and most recent studies in 
large Brazilian cities point to 100% coverage [26, 27]. 
All maternal deaths occurred in 2020 were included in 
our analyses.
We estimated maternal mortality ratio (MMR) by 
dividing the number of maternal deaths by the num-
ber of live births, multiplied by 100,000, for each 
month and year [28]. Annual (from 2011 to 2020) and 
monthly (from January to December 2020) MMR were 
plotted on a time curve. The COVID-19 incidence in 
Bahia, per month in 2020, was calculated by the ratio 
between the number of new cases of this disease and 
the population estimate, followed by the multiplication 
by 100,000.
The time trend of MMR in the period from 2011 to 
2020 was verified through polynomial regression analy-
sis, of order 6. The additive Holt-Winters exponen-
tial smoothing model (ETS A, A, A), which considers 
the additive parameters error, trend and seasonality, 
was used to analyse the MMR time series 2011–2019 
and predict the values for 2020, with a 95% confidence 
interval. Then, the real MMR values recorded in Bahia 
in 2020 were compared to those expected. The accu-
racy of the monthly and yearly MMR forecasts for 2020 
was assessed by checking the Alpha, Beta and Gamma 
smoothing coefficients and the values of Scaled Mean 
Absolute Error (MASE), Symmetric Mean Percentage 
Absolute Error (sMAPE), Mean Absolute Error (MAE) 
and Root of the Mean Quadratic Simulation Error 
(RMSE).
As this study was carried out using public domain data, 
it was not necessary to submit it to the Research Ethics 
Committee.
Results
Between 2011 and 2013, the MMR in Bahia increased by 
12.1%. From 2013 to 2019, it was decreasing (-35.13%) 
over the years. However, in 2020, the MMR was 
78.23/100,000 live births (lb.), an excess of 59,46% from 
the expected for this year (49.06 [95% CI 38.70–59.90]) 
(Fig. 1).
From January to April 2020, the predicted MMR values 
were not significantly different from the observed values 
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for this period. Following a time pattern of increase and 
decrease like the COVID-19 incidence curve, in May 
the MMR increased and was close to the predicted 
maximum limit (Recorded MMR = 85.68/100,000 l.b.; 
Expected MMR = 49.36 [CI95% 10.32–88.41]). After that, 
the MMR exceeded the values expected for the period 
in June (Recorded MMR = 116.92/100,000 l.b.; Expected 
MMR = 49.05 [CI95% 9.80–88.31]), July (Recorded 
MMR = 93.48/100,000 l.b.; Expected MMR = 48.74 
[CI95% 9.27–88.20]), September (Recorded 
MMR = 99.58/100,000 l.b.; Expected MMR = 48.11 
[CI95% 8.22–88.00]) and December (Recorded 
MMR = 104.25/100,000 l.b.; Expected MMR = 47.17 
[CI95% 6.62–87.72]) (Fig. 2).
From May to August, the COVID-19 pandemic rose 
sharply in Bahia, and its incidence per month reached 
99.23, 374.37, 624.26, 608.97 / 100,000 inhabitants 
(inh.), respectively. A slight reduction in the incidence 
of COVID-19 was noted in September (361.72/100,000 
inh.) and October (286.63/100,000 inh.), followed by a 
further increase in November (335.60/100,000 inh.) and 
December (607.33/100,000 inh.).
Of the 144 maternal death recorded in 2020, 19 
(13.19%) were related to COVID-19 (Table  1) and 
occurred in the months April (01), May (02), June (05), 
July (06), September (02) and December (03). Of these, 
15 death certificates contained mention of ICD-10 
U071 (COVID-19, identified virus) among the causes of 
death, which means a SARS-CoV-2 infection diagnosed 
by laboratory examination, and 04 contained mention 
of ICD-10 U072 (COVID-19, unidentified virus), which 
represents diagnosis by clinical-epidemiological and 
imaging exams.
Discussion
This study shows the rise in maternal mortality ratio in 
Bahia in 2020, insofar the officially recorded maternal 
deaths are far higher than the expected number for this 
year. A temporal relationship with COVID-19 pandemic 
was observed, since months in which the maternal mor-
tality ratio exceeded the predicted value coincided with 
those with the highest incidence of COVID-19 in the 
state. The small number of maternal death certificates 
with COVID-19 diagnosed among the causes of death, 
which alone do not justify the excess of deaths observed 
in 2020, and leads us to consider the possibility of under 
diagnoses, since Brazil has not implemented universal 
testing of pregnant women [8] for COVID-19, and poten-
tial indirect effects of the pandemic. Maternal deaths 
attested due to not specified or ill-defined causes, related 
to ICD-10 O98.5—Other viral diseases complicating 
pregnancy, childbirth and the puerperium, for example, 
J18.9—Pneumonia, of unspecified aetiology or U04.9—
Severe acute respiratory syndrome [SARS] unspecified, 
can mask undiagnosed cases of COVID-19.
Maternal deaths could result from maternal illness 
directly related to COVID-19 infection or an indirect 
effect of health service disruptions, and other indirect 
Fig. 1 Maternal Mortality Ratio time series (per 100,000 live births) 2011–2019, and recorded* versus  predicted** values for 2020, with 95% 
confidence interval. Bahia, Brazil, 2011–2020. Source: Brazilian’s Mortality Information System (SIM/DATASUS) and Live Birth Information System 
(SINASC/DATASUS). *Data updated on February 04, 2021. ** Values for 2020 predicted by Holt‑Winters additive exponential smoothing, based on 
the 2011–2019 yearly MMR time series. Smoothing coeficients: Alpha = 0.75; Beta = 0.00; Gamma = 0.00. Forecast Accuracy: Scaled Mean Absolute 
Error (MASE) = 0.75; Symmetric Mean Percentage Absolute Error (sMAPE) = 0.07; Mean Absolute Error (MAE) = 4.56; Root of the Mean Quadratic 
Simulation Error (RMSE) = 5.53
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effects caused by the pandemic. First, maternal deaths 
directly related to COVID-19 in Brazil has been alarmed 
high [8]. However, it is also important to consider the 
possible indirect contributions of the pandemic in the 
occurrence of these deaths, as many pregnant women 
have stopped to attend antenatal appointments most 
likely because they did not feel protected against SARS-
CoV-2 infection. Also, there may have been delay or 
resistance from some maternities with a lower level of 
complexity, to provide care to pregnant women with 
flu-like symptoms, or difficulty in the transportation of 
pregnant women to health units of a higher level of com-
plexity located in other municipalities. In addition, some 
of these maternal deaths can still be under epidemio-
logical investigation and analysis by the Epidemiological 
Surveillance Services and the State Maternal Mortality 
Studies Committee, so, the final cause of death can still 
be changed, and some deaths which COVID -19 has not 
been mentioned could emerge after evaluation. Lastly, 
the change in the organization of prenatal services dur-
ing the pandemic, with a limited number of medical 
care provided to avoid crowding in the waiting rooms, 
may have caused delays in care, contributing to maternal 
deaths that could otherwise be avoided.
Maternal mortality is an indicator of access and quality 
of women’s health care [19], and this increase in mater-
nal mortality showed in 2020 represents an unacceptable 
setback, that needs to be better clarified and faced. We 
understand that the public and private health sectors face 
many challenges in ensuring access and adequate care for 
all pregnant women. However, although the impact of the 
COVID-19 pandemic may affect many of them, it must 
be more remarkable for the poorest women, as occur 
already in the maternal mortality from other causes, to 
whom women of greater socioeconomic vulnerability are 
also more affected [18, 29, 30]. Therefore, the COVID-
19 pandemic may exacerbate the social inequalities and 
injustices that already exist in Brazil [31, 32]. 
This study has limitations inherent to the use of i) sec-
ondary data; ii) relatively small number of maternal deaths, 
that makes the time series more susceptible to variations, 
and; iii) preliminary data on maternal deaths in 2020, due 
to possible delays in feeding official information systems. 
In addition, as time series studies correspond to a subtype 
of aggregate (or ecological) studies, they are vulnerable 
to ecological fallacy. Consequently, its results cannot be 
inferred for the individual level. Added to this the fact that 
it is a descriptive study, and thus a cause-effect relation-
ship cannot be inferred from its results. Another limita-
tion refers to the forecasting. In general, in the exponential 
smoothing of time series, the parameter ranges and initial 
values are arbitrary, and this can impair the accuracy of 
the forecast. In our study, it was possible to observe that 
the confidence interval for monthly forecasts was wider, 
indicating that there was less precision in these, when 
compared to the annual estimates. The model applied in 
Fig. 2 Maternal Mortality Ratio (MMR) per 100,000 live births, and the incidence of COVID‑19 per 100,000 inhabitants, per month 2020*, and 
 predicted** MMR values with 95% confidence interval, for the same period. Bahia, Brazil, 2020. Source: Brazilian’s Mortality Information System (SIM/
DATASUS) and Live Birth Information System (SINASC/DATASUS); COVID‑19 Bahia Epidemiological Bulletins No. 01, 04, 35, 67, 98, 129, 160, 190, 221, 
251 and 282/2020. *Data updated on February 04, 2021. **Values for 2020 predicted by Holt‑Winters additive exponential smoothing, based on the 
2011–2019 monthly MMR time series. Smoothing coefficients: Alpha = 0.10; Beta = 0.00; Gamma = 0.00. Forecast Accuracy: Scaled Mean Absolute 
Error (MASE) = 0.57; Symmetric Mean Percentage Absolute Error (sMAPE) = 0.28; Mean Absolute Error (MAE) = 14.16; Root of the Mean Quadratic 
Simulation Error (RMSE) = 16.53
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our study use only the data from the series itself to pro-
ject its forecasting, does not incorporate external vari-
ables, for example, environmental factors, or public policy 
interventions. Despite that, the Holt-Winters (ETS AAA) 
model is considered to be robust and has excellent perfor-
mance for short-term forecasts [33, 34]. Notwithstanding 
these weaknesses, our study suggests devastating con-
sequences for maternal mortality during the COVID-19 
pandemic in Bahia, Brazil. It points to the need to conduct 
more research across the country during the pandemic 
to confirm these estimates and understand the long-term 
impacts of this disease on maternal health.
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